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In dengue virus infections the asymptomatic cases are much more frequent than the symp-
tomatic ones, but their true role in the introduction and subsequent spread of dengue
viruses in non-endemic regions remains to de clariﬁed. We analyzed data from English
and French literatures to assess if viremia in asymptomatic dengue infections might be
sufﬁcient to represent a true risk. During outbreaks of dengue a large number of individ-
uals are infected and since viremia levels in symptomatic patients are known to vary by
many orders of magnitude, it is reasonable to augur that a proportion of asymptomatic
cases might reach levels of viremia sufﬁcient to infect competent mosquitoes. In addition,
a number of new ways of contamination in man by dengue viruses were recently described
such as blood transfusion, bone marrow transplantation, and nosocomial infections that
may be worth considering.
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INTRODUCTION
During the three past decades dengue fever (DF) has shown an
unprecedented geographic expansion whilst the annual number
of cases and the severity of the disease increased dramatically. This
mosquito-borne disease is at present the ﬁrst arboviral disease
infectingmankindworldwide.Anestimated2.5 billionpersons live
in virus endemic areas and 50–100 million cases occur each year,
inducing 500,000 hospitalizations (Halsitead, 2007) and about
20,000 deaths (Strait et al., 2011).
As a direct consequence of the recent establishment of theAedes
albopictus mosquito in many European countries where imported
cases of dengue occur among travelers returning from endemic
areas, European Union Member States are at risk of local out-
breaks. This is particularly evident for Northern Italy (Rovida
et al., 2011) and above all for Southern France (Laruche et al.,
2010) and Croatia (Gjenero-Margan et al., 2011). In each of these
last two countries two autochthonous cases of dengue occurred
in September 2010. These few cases were efﬁciently detected as a
result of the recent implementation of European surveillance pro-
grams in France, Croatia, and Germany. It is the ﬁrst time that
autochthonous transmission of dengue viruses was recorded in
Europe since the historical Greek outbreak of 1927–1928 (Chastel,
2009).
Increased global movement of humans, plants, and
hematophagous arthropods via shipping and air trafﬁc has mul-
tiplied the opportunities for infected travelers and other items to
export dengue viruses from tropical to temperate regions (Chas-
tel, 2007). Whether or not global climate change has worsened the
situation is debatable (Reiter, 2001; Chastel, 2002; Barklay, 2008;
Gould and Higgs, 2009) but it can no longer be ignored.
Moreover, in dengue as in other mosquito-borne arbovirus
infections (Chastel, 2011) the asymptomatic cases are much more
frequent than the symptomatic ones although their true role
in introduction and subsequent spread of dengue viruses in
non-endemic regions remains to be clariﬁed.
This short review therefore examines the concept that asymp-
tomatic disease is an increasingly contributor to the dispersal of
dengue viruses than it may have been previously thought.
METHODS
We have collected pertinent data from English and French lit-
eratures from the 1980s to 2011 through PubMed and other
bibliographic sources including Dengue Net. Data were analyzed
to assess if viremia in asymptomatic dengue infections (dengue1–4
viruses) might be sufﬁcient to represent a true risk for the intro-
duction of these viruses in non-endemic regions. The key-words
we used in searching in databases were: “dengue virus infections,”
“introduction by infected travelers,” “asymptomatic infections,”
“viremia,” and “disease severity.” We thus selected ﬁve articles
dealing with the frequency of asymptomatic cases and seven arti-
cles related to viremia in symptomatic or asymptomatic cases.
In addition we have taken in account both the classical way of
transmission, i.e., bymosquito bite, and the newones recently doc-
umented such as blood transfusion, organ transplantation, needle
stick injury, or intrapartum.
Moreover, some studies concerning the introduction of dengue
viruses in new areas and the Public Health measures implemented
to ﬁght against the consequences of such events were analyzed
(see Beckett et al., 2005; Shu et al., 2005; Shang et al., 2010, for
instance).
RESULTS
ATTEMPTS TO MINIMIZE THE INTRODUCTION AND SPREAD OF
DENGUE VIRUSES IN NEW AREAS
It is almost impossible to intercept asymptomatic or mildly symp-
tomatic travelers arriving from tropical regions and entering a
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non-endemic one.However, it is important to emphasize thatmild
symptoms are a very common feature of arboviruses including the
four dengue viruses (DENV 1–4).
In order to detect potential imported cases of DF and thereby
to reduce the local spread of the introduced viruses, the Taiwanese
Disease Control authorities established an integrated control pro-
gram that included a variety of surveillance systems, capable of
screening for fever in arriving passengers, a network of rapid diag-
nostic laboratories, and other integrated control measures. This
strategy applied between July 2003 and June 2004 identiﬁed 40
conﬁrmed cases of DF, all of which were viremic when tested
by RT-PCR (Shu et al., 2005). Thus, although it proved costly
to implement, this strategy appeared efﬁcient and may be cost
effective in long-term.
However, for other authors infrared skin thermometry did not
appear an effective tool for the detection of febrile patients (Haus-
fater et al., 2008).More importantly this techniquewouldnot detect
asymptomatic individuals.
QUANTIFICATION OF ASYMPTOMATIC CASES IN DENGUE VIRUS
INFECTIONS
In these diseases, the asymptomatic cases are much more fre-
quent than the symptomatic ones, but their relative number varies
according to the geographic area, the epidemiologic context, the
immunological status of patients, and the circulating type(s) of
DENV. This is clearly exempliﬁed by different surveys.
During a prospective survey carried out in 1980–1981 in
Bangkok, Thailand, amongst school children, the authors esti-
mated the ratio of asymptomatic/symptomatic cases to be 6.1:1.
This ratio was reﬁned to 5.5:1 for DENV 1 infections and 4.5:1 for
DENV 2 cases. In addition, the three DENV 4 infections that were
detected during this survey were entirely asymptomatic (Burke
et al., 1988). In contrast, another prospective study was conducted
in Kamphaeng Phet, Northern Thailand, between 1998 and 2000
and the results were quite different since the ratio was only 1.1:1
(Endy et al., 2002).
However, in Nicaragua, Central America, a similar survey car-
ried out between 2001 and 2003 amongst 4- to 16-years-old school
children living in Managua city showed that in 2001, when DENV
2 was prevalent, a ratio of 13:1 was determined. In 2002 this ratio
fell to 6:1 when DENV 1 was the most frequently isolated serotype
(Balmaseda et al., 2006).
In Singapore, South-East Asia, Health authorities assumed a
ratio of asymptomatic/symptomatic infections between 2:1 and
10:1. This was considered to represent a very serious threat for
blood transfusion recipients (Wilder-Smith et al., 2009).
Finally, amongst Dutch travelers infected between October
2006 and September 2007 in different tropical countries a ratio
of 1.8:1 was observed. In this study the type of infecting DENV
was not determined since only serologic testing was performed
(Baaten et al., 2011).
Thus, according to these surveys, the ratio of asympto-
matic/symptomatic cases of dengue virus infection may exten-
sively vary. These differences might be explained by individual
variations in susceptibility or variability in the virulence of DENV
strains (Balmaseda et al., 2006). Alternatively the epidemiology of
dengue may differ in South-East Asia and the Americas (Halstead,
2006).
WHAT ARE THE RISKS ASSOCIATED WITH ASYMPTOMATIC DENGUE
VIRUS INFECTIONS?
In non-endemic regions, it is well established that DENV are being
introduced by viremic travelers returning from endemic or epi-
demic areas, although whether or not they subsequently cause
outbreaks depends on a number of crucial requisites: ﬁrstly, the
infected traveler should be sufﬁciently viremic to be capable of
infecting local mosquitoes; secondly, this mosquito would need to
be a highly competent species and sufﬁciently abundant at the
time of virus introduction to ensure its diffusion; thirdly, the local
population would need to be highly receptive to DENV. Finally,
favorable meteorological conditions represent critic factors for
initiating local dengue epidemics in Taiwan (Shang et al., 2010).
Moreover, in both endemic and non-endemic regions,we know
that blood transfusion, organ transplantation, and needle stick
injuries represent new identiﬁed risks of infection by DENV
(Hirch et al., 1990; deWazières et al., 1998; Rigan-Perez et al., 2001;
Langgartner et al., 2002; Chen and Wilson, 2004; Nemes et al.,
2004; Wagner et al., 2004; Wilder-Smith et al., 2009). Intrapartum
is another unusual route of contamination by DENV (Hirch et al.,
1990; Rigan-Perez et al., 2001; Tran and Chastel, 2008). All these
atypical ways of contamination may originate in a silent infec-
tion, either pre-clinic, very mild, or totally asymptomatic. In our
opinion, these new modes of contamination greatly increase the
opportunities for introduction of DENV in non-endemic regions
by asymptomatic individuals.
MAGNITUDE OF VIREMIA IN ASYMPTOMATIC CASES OF DENGUE
VIRUS INFECTIONS
To accurately appreciate the eventual role of asymptomatic cases
for the introduction and spread of DENV in non-endemic regions,
it is necessary to try to quantify the level of viremia in such infected
persons. This is a basic, presently poorly documented problem.
Indeed, even though asymptomatic cases predominate during
epidemics, the precise levels of viremia in such cases remain to be
evaluated.
There are two studies using virological methods and taking
up the problem of the viremia in asymptomatic cases of dengue
infections.
The ﬁrst was conducted, in 2001–2003, inWest Jakarta, Indone-
sia, and showed that viremia might be detected in asymptomatic
cases by RT-PCR or virus isolation: on day 10 during a DENV 1
infection in one individual and in day 4 during a DENV 2 infection
in another one. Unfortunately, the RT-PCR method used in this
study was only qualitative and thus the precise level of viremia was
not established (Beckett et al., 2005).
The second study was performed during the 2006 and 2007
epidemics in Kampong Cham,Cambodia. Using NS1 antigen cap-
ture, real time RT-PCR, and MAC–ELISA assays, dengue infection
was conﬁrmed in 243 symptomatic patients and in 17 asympto-
matic family-related individuals. All four dengue serotypes were
identiﬁed. As this study was essentially devoted to assess if the
NS1 antigenemia might represent a good early marker of the
disease severity, it is difﬁcult to precisely evaluate the levels of
viremia in asymptomatic cases. In fact, the authors stated that
“the level of viremia in asymptomatic cases was not signiﬁcantly
lower in asymptomatic cases than in all dengue conﬁrmed cases
(p = 0.145)” (Duong et al., 2011).
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These scarce and partial results force us to use data estab-
lished in symptomatic cases to better evaluate the viremia levels in
asymptomatic ones.
MAGNITUDE OF VIREMIA IN SYMPTOMATIC CASES OF DENGUE VIRUS
INFECTIONS
During a severe outbreak of DF in French Polynesia during 1996
and 1997, the plasma DENV 2 titers ranged from 1.7 to 5.6 log 10
TCID50/ml in hospitalized children and the mean duration of the
viremia was 4.4 days (Murgue et al., 2000).
In Thailand, viremia titers were determined in 168 children
with acute dengue virus infections (DENV 1–4) and two different
hospitals (Vaughn et al., 2000). Duration of viremia ranged from
1 to 7 days and the higher mean titer was 107.6 MID50/ml median
mosquito infectious dose (MID) for patients with DF versus 108.5
MID50/ml for patients with hemorrhagic fever. Thus, the severity
of the disease was, in this study, clearly associated with the higher
titers of viremia.
The same observation was done in Taiwan during a DENV 3
epidemic in 1998. A total of 20 patients, 11 with DF and 9 with
dengue hemorrhagic fever (DHF) were studied using a quantita-
tiveRT-PCR.The viremiawas foundunder the detection threshold
of the method (<600 RNA copies/ml) in ﬁve of the DF patients
and between 3,900 and 3,710,000 RNA copies/ml in six others. In
contrast, in nine DHF patients the viremia levels extended from
46,700 to 14,900,000 RNA copies/ml. These high levels of plasma
RNA persisted during defervescence in DHF patients whilst they
declined to a level below detection in DF patient. DENV persisting
in plasma during defervescence were into immune complexes in
most DHF patients (Wang et al., 2003).
Another survey was carried out amongst 80 Thai children using
a RT-PCR method able to quantify all the four DENV serotypes.
Plasma RNA levels ranged between 5 × 103 and 5 × 109 copies/ml
(Sudiro et al., 2001).
In Singapore, Public Health authorities estimate DENV
plasma viral RNA levels ranging from 105.5 to 109.3 copies/ml
(Wilder-Smith et al., 2009). They also suggested: “it is likely,
although not proven, that viremia is lower and shorter in duration
in asymptomatic persons than in symptomatic persons.” In the
absence of any systematic study in this ﬁeld such opinion can only
be speculative.
On the contrary, it seems reasonable to assume that some
asymptomatic cases must achieve viremia levels as high as the
lowest estimates for symptomatic cases. In fact, from the above
data it is evident that the viremic levels in DF patients are both
highly variable and geographically widely dispersed. Therefore it
is entirely reasonable to hypothesize that similar dispersion and
high variability of virus titers might be present in asymptomatic
individuals.
Taking this to the next logical step, if a competent mosquito
vector such as A. albopictus is already established in non-endemic
regions, for instance Southern Europe, the risk that asymptomatic
dengue virus infection could provide the source of new foci of dis-
ease or eventually epidemics is likely. Moreover, the existence of
atypical ways of contamination reinforce the probability of such a
scenario.
CONCLUSION
Dengue virus infections cause asymptomatic infections much
more frequently than symptomatic cases, sometimes multiplying
up to 14 the actual number of infections, but their true role in the
introduction and subsequent spread of DENV in non-endemic
regions remains to be clariﬁed.
Since very large numbers of individuals are infected and
since viremic levels are known to vary by several orders
of magnitude in symptomatic patients it is reasonable to
argue that at least a proportion of asymptomatic cases might
reach levels of viremia sufﬁcient to infect competent mosquito
vectors.
In addition, the existence of newly recognized ways of cont-
amination in man such blood transfusion, bone marrow trans-
plantation, and nosocomial infections offer other opportuni-
ties for DENV to be introduced and spread in non-endemic
regions.
More virological studies are needed on asymptomatic cases of
dengue to valid or not these hypotheses.
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